PREDICTING HUMAN DEVELOPMENTAL TOXICITY OF PHARMACEUTICALS USING HUMAN STEM-LIKE CELLS AND METABOLOMICS
摘要
<p>The invention provides biomarker profiles of metabolites and methods for screening chemical compounds including pharmaceutical agents, lead and candidate drug compounds and other chemicals using human stem-like cells (hSLCs) or lineage-specific cells produced therefrom. The inventive methods are useful for testing toxicity, particularly developmental toxicity and detecting teratogenic effects of such chemical compounds. Specifically, a more predictive developmental toxicity model, based on an in vitro method that utilizes both hSLCs and metabolomics to discover biomarkers of developmental toxicity is disclosed.</p>
申请公布号
WO2011119637(A9)
申请公布日期
2015.12.10
申请号
WO2011US29471
申请日期
2011.03.22
申请人
STEMINA BIOMARKER DISCOVERY, INC.;WEST, PAUL, R.;WEIR, APRIL, M.;SMITH, ALAN, M.;DONLEY, ELIZABETH, L.R.;CEZAR, GABRIELA, G.
发明人
WEST, PAUL, R.;WEIR, APRIL, M.;SMITH, ALAN, M.;DONLEY, ELIZABETH, L.R.;CEZAR, GABRIELA, G.